|Gender-related outcome difference is related to course of sepsis on mixed ICUs: a prospective, observational clinical study.|
|Jump to Full Text|
|PMID: 21693012 Owner: NLM Status: MEDLINE|
|INTRODUCTION: Impact of gender on severe infections is in highly controversial discussion with natural survival advantage of females described in animal studies but contradictory to those described human data. This study aims to describe the impact of gender on outcome in mixed intensive care units (ICUs) with a special focus on sepsis.
METHODS: We performed a prospective, observational, clinical trial at Charité University Hospital in Berlin, Germany. Over a period of 180 days, patients were screened, undergoing care in three mainly surgical ICUs. In total, 709 adults were included in the analysis, comprising the main population ([female] n = 309, [male] n = 400) including 327 as the sepsis subgroup ([female] n = 130, [male] n = 197).
RESULTS: Basic characteristics differed between genders in terms of age, lifestyle factors, comorbidities, and SOFA-score (Sequential Organ Failure Assessment). Quality and quantity of antibiotic therapy in means of antibiotic-free days, daily antibiotic use, daily costs of antibiotics, time to antibiotics, and guideline adherence did not differ between genders. ICU mortality was comparable in the main population ([female] 10.7% versus [male] 9.0%; P = 0.523), but differed significantly in sepsis patients with [female] 23.1% versus [male] 13.7% (P = 0.037). This was confirmed in multivariate regression analysis with OR = 1.966 (95% CI, 1.045 to 3.701; P = 0.036) for females compared with males.
CONCLUSIONS: No differences in patients' outcome were noted related to gender aspects in mainly surgical ICUs. However, for patients with sepsis, an increase of mortality is related to the female sex.
|Irit Nachtigall; Sascha Tafelski; Andreas Rothbart; Lutz Kaufner; Maren Schmidt; Andrey Tamarkin; Maxim Kartachov; Daniela Zebedies; Tanja Trefzer; Klaus-Dieter Wernecke; Claudia Spies|
|Type: Clinical Trial; Comparative Study; Journal Article Date: 2011-06-21|
|Title: Critical care (London, England) Volume: 15 ISSN: 1466-609X ISO Abbreviation: Crit Care Publication Date: 2011|
|Created Date: 2011-11-17 Completed Date: 2012-08-20 Revised Date: 2013-06-28|
Medline Journal Info:
|Nlm Unique ID: 9801902 Medline TA: Crit Care Country: England|
|Languages: eng Pagination: R151 Citation Subset: IM|
|Department of Anaesthesiology and Intensive Care, Charité Universitaetsmedizin Berlin, Campus Charité Mitte, Augustenburger Platz 1, 13353 Berlin, Germany.|
|APA/MLA Format Download EndNote Download BibTex|
Hospital Mortality / trends
Intensive Care Units / trends*
Sepsis / mortality*, therapy*
|Crit Care. 2011;15(4):180
Journal ID (nlm-ta): Crit Care
Publisher: BioMed Central
Copyright ©2011 Nachtigall et al.; licensee BioMed Central Ltd.
Received Day: 21 Month: 1 Year: 2011
Revision Received Day: 18 Month: 4 Year: 2011
Accepted Day: 21 Month: 6 Year: 2011
Print publication date: Year: 2011
Electronic publication date: Day: 21 Month: 6 Year: 2011
Volume: 15 Issue: 3
First Page: R151 Last Page: R151
Publisher Id: cc10277
PubMed Id: 21693012
|Gender-related outcome difference is related to course of sepsis on mixed ICUs: a prospective, observational clinical study|
|Irit Nachtigall1||Email: email@example.com|
|Sascha Tafelski1||Email: firstname.lastname@example.org|
|Andreas Rothbart1||Email: email@example.com|
|Lutz Kaufner1||Email: firstname.lastname@example.org|
|Maren Schmidt1||Email: email@example.com|
|Andrey Tamarkin1||Email: firstname.lastname@example.org|
|Maxim Kartachov1||Email: email@example.com|
|Daniela Zebedies1||Email: firstname.lastname@example.org|
|Tanja Trefzer1||Email: email@example.com|
|Klaus-Dieter Wernecke2||Email: firstname.lastname@example.org|
|Claudia Spies1||Email: email@example.com|
1Department of Anaesthesiology and Intensive Care, Charité Universitaetsmedizin Berlin, Campus Charité Mitte and Campus Virchow-Klinikum, Augustenburger Platz 1, 13353 Berlin, Germany
2Charité Universitaetsmedizin Berlin and SOSTANA GmbH Berlin, Wildensteiner Straße 27 10318 Berlin, Germany
The impact of gender on severe infections is in highly controversial discussion. A natural survival advantage for females  in data from animal experiments seems to be contradictory to human clinical data on sepsis-related mortality [2-5]. Eachempati et al.  demonstrated female gender as an independent predictor of increased mortality in patients with documented infection in a surgical intensive care unit (ICU). He emphasised that different genders may need different types of therapy. Depending on the chosen subgroup, Combes et al.  reported an increased risk for women to die of nosocomial infections.
Different pathomechanisms were addressed to be responsible for these findings, including sex-related gene polymorphisms , effects of sex hormones , or different intensities of care, with males receiving more invasive procedures [7,8].
One fundamental issue is to make study populations matchable for research projects (for example, for evaluation of new interventions and drugs), but as well to assess the severity of diseases in mixed populations or for benchmarking purposes. Classification systems like PIRO (predisposition, insult/infection, response, organ dysfunction) included gender with the intention of improving the comparability of studies. But although discussion is nearly a decade old, still no agreement is found as to whether female or male gender is a predisposing factor . Le Gall et al.  created an extended version of the Simplified Acute Physiology Score-II (SAPS-II), including gender, giving male patients a higher score for predicting mortality . The author excluded burned and coronary and cardiac surgery patients; the latter is a population in which women probably do worse . Interestingly, it seems to be highly cohort related whether men or women are more likely to survive. This study aims to describe the impact of gender on outcome of patients on mixed ICUs with a special focus on sepsis patients.
This prospective, observational, clinical trial was performed during two 90-day data-acquisition periods from January to March 2006 and February to May 2007 at the Charité University Hospital in Berlin, Germany (tertiary medical care center with 3,200 beds). Three mixed ICUs comprising 61 mainly surgical ICU beds under anesthesiologic management were included.
Patients with ARDS (acute respiratory distress syndrome) or neurologic diagnoses as well as patients from different surgical disciplines, including abdominal, gynecologic, cardiac, and neurosurgery or after severe traumata were screened for inclusion. Every consecutive adult (≥18 years) patient with more than 36 hours of ICU treatment admitted to one of the three ICUs was included prospectively into the study. For the purpose of focusing on anti-infective therapy, only patients with at least one day of antibiotic treatment were included in the analysis.
All patients meeting the criteria for sepsis for at least 1 day during the ICU stay were assigned to a sepsis subgroup. This subgroup was examined independently for primary and secondary study aims.
Data were recorded in daily rounds from medical records, hospital mainframe computer, and patient data-management system (PDMS; Copra System, Sasbachwalden, Germany). Data were collected every day for the preceding 24 hours.
Data on vital signs, laboratory findings, microbiologic and radiologic diagnostics, anti-infective, vasopressor, and steroid agents, ventilation, pulmonary gas exchange, urine output, and fluid balance were taken from the PDMS.
Information regarding alcohol, drug, or nicotine abuse or immunosuppressive status was taken from the patient's data file. The latter was defined for all patients receiving corticosteroids or other immunosuppressive agents, having HIV or leukemia, or after chemotherapy. TISS-28 (Therapeutic Intervention Scoring System-28), SOFA (Sequential Organ Failure Assessment), and SAPS-II (Simplified Acute Physiology Score-II) scoring systems are measured regularly in included ICUs as surrogate markers for disease severity. Infections were screened by using modified definitions of the Centers for Disease Control and Prevention  and the guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia of the American Thoracic Society . Duration of ventilation was defined as the period of mechanical ventilation support during the ICU stay of the patient (intubated or via tracheostomy). ICU stay was defined as number of days a patient remained in the ICU during one hospital stay, including readmissions from regular wards. Sepsis, severe sepsis, and septic shock are defined according to the national and international sepsis guidelines [13-15]. Patients required demonstration of at least two of four signs of systemic inflammatory response syndrome (body temperature, < 36°C or > 38°C; tachycardia, > 90 beats/min; tachypnea, > 20 per minute, or hypocapnia < 32 mm Hg; leukopenia, < 4,000 per milliliter; or leukocytosis, > 12,000 per milliliter or left shift) associated with an infection.
Primary outcome parameter was ICU mortality rate for male and female patients. As secondary outcome measures, quality and quantity of diagnostic efforts and antibiotic therapy were analyzed. Later, evolution of disease severity by using the TISS-28 (Therapeutic Intervention Scoring System) was examined.
SOP (standard operating procedure) adherence was recorded during data collection but was scored afterward by independent experts. Process of assessment of SOP adherence for treatment and diagnostics was previously described in detail .
Time analysis was performed as analysis of sepsis onset, based on the previously mentioned definition and first antibiotic treatment after onset. Duration until antibiotic therapy was estimated between these two time points. Quantity of antibiotics was measured as amount of antibiotic agents per day; prices rely on hospital pharmacy lists from December 2005.
All study results are expressed as median with 25% to 75% quartiles (25|75), arithmetic mean (mean) ± standard deviation (± STD), or proportions [%] as appropriate, depending on the proof for normality. For statistical analysis, Wilcoxon-Mann-Whitney tests, the Student t tests and χ2 tests were performed as appropriate, with a two-tailed P value of < 0.05 considered statistically significant.
Evolution of disease-severity scoring system TISS-28 (Therapeutic Intervention Scoring System) over the clinical course was evaluated by using multivariate nonparametric longitudinal data analysis in a two-factorial design (Brunner analysis). For this analysis, patients were included with at least two sequential values, and number of consecutive days for longitudinal analysis was limited by the days, with at least 50% of the study population providing consistent data. This procedure was chosen a priori to reveal consistent conclusions for the whole population and to reduce the possibility of a selection bias. Finally, the longitudinal analysis compared data of the first consecutive 8 days of the ICU stay. Expected mortality and ratio of observed and expected mortality rates are calculated based on the reported initial SAPS II scoring for each subgroup, as described by Le Gall et al. .
To compare the risk of mortality for both genders, univariate logistic regression analysis was performed separately incorporating different cofactors (age, alcohol abuse, nicotine abuse, drug abuse, immunosuppressive status, admission category, coexisting diagnoses, infection focus, severe sepsis, septic shock, bacteria detected during ICU stay, and surrogate markers for quality of care). For the purpose of affirming the significant effects of gender on mortality, study results were analyzed by using multivariate logistic regression methods. Based on the results of univariate logistic regression analyses, factors with significant association with mortality were incorporated into multivariate analysis. Multivariate regression analyses also included stepwise backward selection to reveal the most relevant associated parameters for mortality to validate the findings. Odds ratios (ORs) with 95% confidence intervals (CIs) and the corresponding P values were calculated for each risk factor. Quality of regression models was assessed with Hosmer-Lemeshow tests for model calibration. All numeric calculations were performed with PASW 18 (SPSS, Inc., Chicago, IL 60606, U.S.A.) and SAS version 9.1 (SAS Institute Inc., 2003, Cary, IN, U.S.A.).
The local Ethics Review Board and the data safety authorities approved this study. The Ethics review board waived the need for patient informed consent to be obtained because of the observational character of the study.
Altogether, 986 patients were screened, and 709 with antibiotic treatment were included in further analyses (Figure 1). This main population included 309 women and 400 men, with 130 women and 197 men with sepsis comprising the sepsis subgroup for further analysis.
In the main population, basic characteristics differed between genders in means of age, drug abuse, nicotine abuse, alcohol abuse, vascular diseases, and median SOFA Score on admission. Duration of mechanical ventilation for patients with ventilation support was shorter for women than for men, as displayed in Table 1. Other parameters, like length of ICU stay, immunosuppressive status, comorbidities, admission categories, surgical category, SAPS-II, and TISS-28 on admission did not differ between genders.
Subgroup analysis for sepsis patients showed differences of basic characteristics in age, drug abuse, alcohol abuse, immunosuppressive status, vascular disease, and median SOFA Score on admission, as summarized in Table 1. Other parameters like duration of mechanical ventilation, length of ICU stay, comorbidities, admission categories, surgical category, SAPS-II, and TISS-28 on admission did not differ between genders.
In the main population, microbiologic diagnostics in relation to length of ICU stay (% LOS) did not differ, but radiologic diagnostics was reduced for women (Table 1). A higher percentage of men had an infection, and pneumonia was less often seen in women, but conversely, lower urinary tract infections were more common in women (Table 2). Notably, quality of antibiotic therapy in means of antibiotic-free days, daily antibiotic use (DAU) in agents per day, daily costs of antibiotics, and SOP adherence in percentage of all ICU days did not differ between genders (Table 1).
Similarly, in the sepsis subgroup, radiologic diagnostics was performed less often in women (Table 1). Distribution of urinary tract infections differed significantly between males and females (Table 2). The remaining parameters were equally distributed between groups (Tables 1 and 2).
For the sepsis subgroup, no statistically significant difference appeared for the time to antibiotics. Duration from onset of sepsis to antibiotic therapy in median was ♀ 0.54 h (25%|75% Quartiles 0.0|4.70 h) versus ♂ 1.5 h (25%|75% quartiles, 0.0|6.25 h; P = 0.126).
ICU mortality in the main study population was equal between both genders (♀ 10.7% versus ♂ 9.0%; P = 0.523), but differed significantly in the sepsis subgroup (♀ 23.1% versus ♂ 13.7%; P = 0.037), as displayed in Figure 2.
The O/E mortality rate in the main population was 0.539 (95% CI, 0.378 to 0.747) for men and 0.699 (95% CI, 0.481 to 0.981) for women; in the sepsis population 0.596 (95% CI, 0.393 to 0.869) for men and 0.935 (95% CI, 0.629 to 1.332) for women, respectively .
In the female population, in 2.9%, therapy was discontinued. In male patients, this proportion was nearly equally contributed with 2.3% of patients, P = 0.634.
With univariate logistic regression, risk factors for mortality were assessed (Table 3). For the main study, population age, TISS-28 on admission, occurrence of infection during ICU stay, pneumonia, and septic shock were significantly associated with mortality. Alternatively to TISS-28, severity of disease scoring system SAPS-II also showed this association, with an OR of 1.066 (95% CI, 1.048 to 1.085). Additionally, difficult-to-treat pathogens and SOP adherence < 65% were also significantly associated with mortality.
Based on these findings, a multivariate logistic regression model was performed to affirm the effect of gender adjusted to other relevant factors for mortality. The resulting odds ratio for the parameter gender was 1.277 for women compared with men but without reaching a level of significance (Table 3).
The same methods were used to evaluate the sepsis subgroup with gender, age, TISS-28 on admission, occurrence of pneumonia, septic shock, and adherence to SOPs < 65% significantly associated with ICU mortality (Table 4). The resulting multivariate logistic regression model showed gender as a significant factor for mortality in this population, with an odds ratio of 1.909 for women compared with men in the full model. A stepwise backward-selection procedure reproduced this finding in a reduced model with four variables (gender, age, TISS-28 on admission, and septic shock), with an OR for mortality of 1.966 for women compared with men (Table 5).
Evolution of TISS-28 scoring for severity of disease for men and women was compared via Brunner analysis over the first eight consecutive ICU days. Differences between groups were statistically significant in the nonparametric multivariate analysis for longitudinal data for the first independent factor, Gender (P < 0.001), and for interaction between Gender and Time (P = 0.029) but not for the second dependent factor, Time (P = 0.063). In the sepsis subgroup, differences between groups were statistically significant for Gender (P = 0.018) but not for Time (P = 0.257) and for the interaction between Gender and Time (P = 0.662). These findings are also reflected in Figure 3, illustrating the different development of TISS-28 over time for women and men despite initially similar levels.
Most important, we were able to demonstrate that a gender-related effect on mortality is limited to the specific subgroup of sepsis patients. Further, we showed that despite smaller differences in the care process, quality and quantity of key interventions in infection management are distributed equally between genders. These findings contribute to the discussion of whether different levels of care have an impact on gender-related outcome [8,17,18].
Concerning distribution of basic characteristics, we were able to reproduce well-described differences between genders comparing lifestyle risks, comorbidities, and age [3,8]. Similarly, subgroup analysis for sepsis patients showed differences in basic characteristics for age, lifestyle risks, immunosuppressive status, and vascular disease. Women had lower SOFA score on admission in the main study population as well as in the sepsis subgroup. This finding is well described for other study populations . However, primary assessed scores reflect only the moment of admission but not the kinetic of clinical course, for which SOFA is not validated . Because this scoring system does not take gender into account [21,22], the gender-related difference in mortality is not reflected well and remains a topic that must be elucidated.
Quantity of microbiologic diagnostics did not differ between genders, but in men, more radiologic diagnostics were performed. This is consistent with the findings of Valentin et al. , that men are more likely to obtain a higher intensity of care in ICU. Furthermore in our study, no differences were found for antibiotic-free days, daily antibiotic use, daily costs of antibiotics, and SOP adherence in percentage of all days--neither in the main study population nor in the sepsis subgroup--showing that in our study population, men and women get the same quality and quantity of care in means of antibiotic therapy. As time to antibiotics was found to be relevant for ICU mortality, we also included this parameter in our analysis but did not find significant differences between genders .
In women, pneumonia as well as overall infection rate was lower, but urinary tract infections occurred more often. This goes along well with previously described data [3,4,24,25]. A higher infection rate in men, mainly based on increased pneumonia rates, may impair survival. Conversely, in our main population, outcome of gender was equal, but in the sepsis subgroup, women were more likely to die than were men. As we think that gender differences are a matter of subgroup selection, this finding is in concordance with other published studies in mixed ICUs, where several differences for gender, but not for mortality, are described . Experimental data show a natural survival advantage after polymicrobial sepsis for women , but human studies focusing the impact of gender on sepsis-related mortality gave inconsistent results, showing a lower [7,19], equal [26,27] or higher [5,28-30] mortality rate. Vincent et al.  reported, in their European multicenter cohort, higher mortality for women with sepsis than for men . Combes et al. , studying ICU patients with sepsis, reported that female gender predicted mortality, although in the univariate analysis, mortality was not significantly different. Seymour et al.  reported a higher mortality rate for women with Fournier gangrene, with more male patients surviving the septic phase. In contrast to this, Adrie et al.  found a survival advantage in women older than 50 years, which is also opposed to our findings . In that study, Adrie et al. postulated women older than 50 years to be postmenopausal without measuring hormone status, which seems to be of high importance. Further on, they included only community-acquired sepsis and predominantly medical patients, which is a difference from our and other study populations. The results of the O/E mortality rate suggest that the SAPS-II score provides the most reliable predictive values for the subgroup of women with sepsis. It is an interesting finding that might indicate a limitation of intensive care scoring systems.
In our study, we also analyzed evolution of TISS-28 scoring for men and women. We found consistent differences between genders being statistically significant. As TISS-28 is a surrogate parameter for intensity of care, our results coincide with the findings that men receive more invasive procedures than do women, regardless of the reason of admission or procedures [7,8]. Conversely, TISS-28 was thought to be used to compare predicted survival in different populations [21,22]. Based on these findings, it might be difficult to use scoring systems not incorporating gender as an independent factor for ICU mortality.
Our study has several limitations. First, data were collected in one tertiary care center but with three ICUs with a very mixed population.
Second, we did not measure sex-hormone levels and did not stratify for age, because postmenopausal status is difficult to assess without measuring sex hormones. As experimental data showed an influence of sex hormones on outcome, this might alter our results. These data advocate further prospective trials with specific focus on this issue.
Third, we did not take into account marital status, which is meant to have an influence on mortality from sepsis . Although having probably the same impact on both genders, the fact that data were collected only during winter and spring could theoretically represent another limitation.
Fourth, 81.8% of our patients are surgical, so results for medical patients might be different.
Finally, studies of gender-related differences are limited to nonrandomized designs. As in studies of other not-modifiable factors like hospital admission time, ethnicity, or genotype we cannot rule out the possibility of further confounders or interactions that were not addressable in our careful multivariate evaluation .
In our population, it seems as if only in a sepsis subgroup gender makes a difference and that if women develop sepsis, they do worse than men. Thus, as sepsis occurred more frequently in male patients, prevention measures for infections might be more important for men, but we should pay more attention to specific therapies for women, because of their higher attributable mortality if seriously infected.
• Gender-related effect on mortality is limited to the specific subgroup of sepsis patients.
• Quality and quantity of key interventions in infection management are distributed equally between genders.
• ICU scoring systems should take gender into account as an independent factor for mortality.
ARDS: acute respiratory distress syndrome; BSI: bloodstream infection; DAU: daily antibiotic use; ESBL: extended spectrum betalactamase; ICU: intensive care unit; LOS: length of stay; MRSA: methicillin-resistant Staphylococcus aureus; OP: operation; PDMS: patient data-management system; PIRO: predisposition, insult/infection, response, organ dysfunction; SAPS-II: simplified acute physiology score-II; SIRS: systemic inflammatory response syndrome; SOFA: sequential organ-failure assessment; SOP: standard operating procedure; STD: standard deviation; TISS-28: therapeutic intervention scoring system-28; VRE: vancomycin-resistant enterococcus.
IN and ST received funding from Roche GmbH. AT received funding from SIRS-Lab GmbH Jena. CS was funded by Merck Sharp and Dohme GmbH, Astra Zeneca, Bristol-Myers Squibb GmbH, Pfizer, and Fresenius Kabi. KDW, DZ, MS, MK, LK, and AR declare that they have no competing interests. No involvements existed in study design, in the collection, analysis, and interpretation of data, in the writing of the report, or in the decision to submit the paper for publication.
IN, ST, DZ, MK, and CS worked out the design and conception of the study and were responsible for data acquisition, analyses, and interpretation. IN, ST, LK, and MS revised the primary study data. ST and KDW performed statistical analyses and prepared the presentation. IN and ST drafted the final manuscript in equal parts. TT, AR, and AT revised all presented data and reevaluated the manuscript. The corresponding author had full access to all the data in the study and had final responsibility for the decision to submit for publication. All authors read and approved the manuscript for publication.
|Zellweger R,Wichmann MW,Ayala A,Stein S,DeMaso CM,Chaudry IH,Females in proestrus state maintain splenic immune functions and tolerate sepsis better than malesCrit Care MedYear: 19972510611010.1097/00003246-199701000-000218989185|
|Hubacek JA,Stuber F,Frohlich D,Book M,Wetegrove S,Ritter M,Rothe G,Schmitz G,Gene variants of the bactericidal/permeability increasing protein and lipopolysaccharide binding protein in sepsis patients: gender-specific genetic predisposition to sepsisCrit Care MedYear: 20012955756110.1097/00003246-200103000-0001511373419|
|Combes A,Luyt CE,Trouillet JL,Nieszkowska A,Chastre J,Gender impact on the outcomes of critically ill patients with nosocomial infectionsCrit Care MedYear: 2009372506251110.1097/CCM.0b013e3181a569df19602974|
|Napolitano LM,Greco ME,Rodriguez A,Kufera JA,West RS,Scalea TM,Gender differences in adverse outcomes after blunt traumaJ TraumaYear: 20015027428010.1097/00005373-200102000-0001311242292|
|Eachempati SR,Hydo L,Barie PS,Gender-based differences in outcome in patients with sepsisArch SurgYear: 19991341342134710.1001/archsurg.134.12.134210593332|
|Federman DD,The biology of human sex differencesN Engl J MedYear: 20063541507151410.1056/NEJMra05252916598047|
|Ayanian JZ,Epstein AM,Differences in the use of procedures between women and men hospitalized for coronary heart diseaseN Engl J MedYear: 199132522122510.1056/NEJM1991072532504012057022|
|Valentin A,Jordan B,Lang T,Hiesmayr M,Metnitz PG,Gender-related differences in intensive care: a multiple-center cohort study of therapeutic interventions and outcome in critically ill patientsCrit Care MedYear: 2003311901190710.1097/01.CCM.0000069347.78151.5012847381|
|Angus DC,Burgner D,Wunderink R,Mira JP,Gerlach H,Wiedermann CJ,Vincent JL,The PIRO concept: P is for predispositionCrit CareYear: 2003724825110.1186/cc219312793879|
|Le Gall JR,Lemeshow S,Saulnier F,A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter studyJAMAYear: 19932702957296310.1001/jama.270.24.29578254858|
|Garner JS,Jarvis WR,Emori TG,Horan TC,Hughes JM,CDC definitions for nosocomial infections, 1988Am J Infect ControlYear: 19881612814010.1016/0196-6553(88)90053-32841893|
|American Thoracic Society and Infectious Diseases Society for AmericaGuidance for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumoniaAm J Respir Crit Care MedYear: 200517138841615699079|
|Dellinger RP,Levy MM,Carlet JM,Bion J,Parker MM,Jaeschke R,Reinhart K,Angus DC,Brun-Buisson C,Beale R,et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008Intensive Care MedYear: 200834176010.1007/s00134-007-0934-218058085|
|Levy MM,Fink MP,Marshall JC,Abraham E,Angus D,Cook D,Cohen J,Opal SM,Vincent JL,Ramsay G,2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions ConferenceIntensive Care MedYear: 20032953053812664219|
|Brunkhorst FM,Engel C,Ragaller M,Welte T,Rossaint R,Gerlach H,Mayer K,John S,Stuber F,Weiler N,et al. Practice and perception: a nationwide survey of therapy habits in sepsisCrit Care MedYear: 2008362719272510.1097/CCM.0b013e318186b6f318766100|
|Nachtigall I,Tamarkin A,Tafelski S,Deja M,Halle E,Gastmeier P,Wernecke KD,Bauer T,Kastrup M,Spies C,Impact of adherence to standard operating procedures for pneumonia on outcome of intensive care unit patientsCrit Care MedYear: 20093715916610.1097/CCM.0b013e3181934f1b19050600|
|Angus DC,Linde-Zwirble WT,Lidicker J,Clermont G,Carcillo J,Pinsky MR,Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of careCrit Care MedYear: 2001291303131010.1097/00003246-200107000-0000211445675|
|Pietropaoli AP,Glance LG,Oakes D,Fisher SG,Gender differences in mortality in patients with severe sepsis or septic shockGender MedYear: 2010742243710.1016/j.genm.2010.09.005|
|Adrie C,Azoulay E,Francais A,Clec'h C,Darques L,Schwebel C,Nakache D,Jamali S,Goldgran-Toledano D,et al. Influence of gender on the outcome of severe sepsis: a reappraisalChestYear: 20071321786179310.1378/chest.07-042017890473|
|Angstwurm MW,Gaertner R,Schopohl J,Outcome in elderly patients with severe infection is influenced by sex hormones but not genderCrit Care MedYear: 2005332786279310.1097/01.CCM.0000190242.24410.1716352961|
|Vincent JL,Moreno R,Clinical review: scoring systems in the critically illCrit CareYear: 20101420720392287|
|Lewandowski K,Lewandowski M,[Scoring systems in the intensive care unit]AnaesthesistYear: 20035296598710.1007/s00101-003-0550-714628794|
|Ferrer R,Artigas A,Suarez D,Palencia E,Levy MM,Arenzana A,Perez XL,Sirvent JM,Effectiveness of treatments for severe sepsis: a prospective, multicenter, observational studyAm J Respir Crit Care MedYear: 200918086186610.1164/rccm.200812-1912OC19696442|
|Gannon CJ,Pasquale M,Tracy JK,McCarter RJ,Napolitano LM,Male gender is associated with increased risk for postinjury pneumoniaShockYear: 20042141041410.1097/00024382-200405000-0000315087816|
|Croce MA,Fabian TC,Malhotra AK,Bee TK,Miller PR,Does gender difference influence outcome?J TraumaYear: 20025388989410.1097/00005373-200211000-0001312435939|
|Crabtree TD,Pelletier SJ,Gleason TG,Pruett TL,Sawyer RG,Gender-dependent differences in outcome after the treatment of infection in hospitalized patientsJAMAYear: 19992822143214810.1001/jama.282.22.214310591336|
|Wichmann MW,Inthorn D,Andress HJ,Schildberg FW,Incidence and mortality of severe sepsis in surgical intensive care patients: the influence of patient gender on disease process and outcomeIntensive Care MedYear: 20002616717210.1007/s00134005004110784304|
|Seymour CW,Iwashyna TJ,Cooke CR,Hough CL,Martin GS,Marital status and the epidemiology and outcomes of sepsisChestYear: 201013712896 Epub 2010 Feb 19. 10.1378/chest.09-266120173054|
|Vincent JL,Sakr Y,Sprung CL,Ranieri VM,Reinhart K,Gerlach H,Moreno R,Carlet J,Le Gall JR,Payen D,Sepsis in European intensive care units: results of the SOAP studyCrit Care MedYear: 20063434435310.1097/01.CCM.0000194725.48928.3A16424713|
|Mercado-Martinez J,Rivera-Fernandez R,Aguilar-Alonso E,Garcia-Alcantara A,Estivill-Torrull A,Aranda-Leon A,Guia-Rambla MC,Fuset-Cabanes MP,APACHE-II score and Killip class for patients with acute myocardial infarctionIntensive Care MedYear: 2010361579158610.1007/s00134-010-1832-620333355|
|Kuijsten HA,Brinkman S,Meynaar IA,Spronk PE,van der Spoel JI,Bosman RJ,de Keizer NF,Abu-Hanna A,de Lange DW,Hospital mortality is associated with ICU admission timeIntensive Care MedYear: 2010361765177110.1007/s00134-010-1918-120549184|
Distribution of basic characteristics between gender in the main population and in the sepsis subgroup
|Main population||Sepsis population|
|n = 400||n = 309||n = 197||n = 130|
|Age (years)||66 (51|72)a||68 (54|78)a||64 (50|72)a||68 (57|78)a|
|Drug abuse||18 (4.5%)a||3 (1.0%)a||14 (7.1)a||1 (0.8)a|
|Nicotine abuse||56 (14.0%)a||15 (4.9%)a||25 (12.7)||9 (6.9)|
|Alcohol abuse||55 (13.8%)a||10 (3.2%)a||33 (16.8)a||8 (6.2)a|
|Immunosuppressive status||27 (6.8%)||31 (10.0%)||11 (5.6%)a||18 (13.8%)a|
|Vascular disease||202 (50.5%)a||111 (35.9%)a||100 (50.8%)a||45 (34.6%)a|
|Hypertension||178 (44.5%)||147 (47.6%)||82 (41.6%)||60 (46.2%)|
|Chronic liver disease||32 (8.0%)||16 (5.2%)||17 (8.6%)||8 (6.2%)|
|Chronic renal disease||67 (16.8%)||46 (14.9%)||37 (18.8%)||24 (18.5%)|
|Metabolic disease||172 (43.0%)||141 (45.6%)||102 (51.8%)||71 (54.6%)|
|Chronic lung disease||45 (11.3%)||37 (12.0%)||27 (13.7%)||20 (15.4%)|
|Psychiatric disease||81 (20.3%)||47 (15.2%)||53 (26.9%)||31 (23.8%)|
|Infection||14 (3.5%)||10 (3.2%)||10 (5.1%)||7 (5.4%)|
|Malignant tumor||65 (16.3%)||80 (25.9%)||27 (13.7%)||21 (16.2%)|
|Neurology||43 (10.8%)||34 (11.0%)||23 (11.7%)||20 (15.4%)|
|Cardiovascular||154 (38.5%)||90 (29.1%)||67 (34.0%)||34 (26.2%)|
|Respiratory||21 (5.3%)||17 (5.5%)||15 (7.6%)||16 (12.3%)|
|Gastrointestinal||30 (7.5%)||19 (6.1%)||20 (10.2%)||9 (6.9%)|
|Trauma||42 (10.5%)||29 (9.4%)||23 (11.7%)||11 (8.5%)|
|Others||31 (7.8%)||30 (9.7%)||12 (6.1%)||12 (9.2%)|
|Surgical patients||327 (81.8%)||262 (84.8%)||151 (76.6%)||100 (76.9%)|
|OP category of surgical patients|
|Neurosurgical||38 (11.6%)||40 (15.3%)||19 (12.6%)||19 (19.0%)|
|Musculoskeletal||59 (18.0%)||46 (17.6%)||33 (21.9%)||19 (19.0%)|
|Cardiac||134 (41.0%)||65 (24.8%)||52 (34.4%)||20 (20.0%)|
|Abdomen and urogenital||83 (25.4%)||97 (37.0%)||41 (27.2%)||30 (30.0%)|
|Thorax||9 (2.8%)||9 (3.4%)||4 (2.6%)||7 (7.0%)|
|Soft tissue and others||4 (1.2%)||5 (1.9%)||2 (1.3%)||5 (5.0%)|
|Severity of disease scorings|
|SAPS-II on admission||35 (26|47)||34 (26|45)||39 (28|51)||40 (29|53)|
|SOFA on admission||5 (2|8)a||4 (2|7)a||6 (4|9)a||5 (3|7)a|
|TISS-28 on admission||35 (26|42)||33 (27|40)||37 (29|44)||35 (28|41)|
|Microbiologic diagnostics (% of LOS)||17.0 (± 20.4)||14.9 (± 19.8)||27.6 (± 19.3)||24.3 (± 17.3)|
|Radiologic diagnostics of (% of LOS)||55.2 (± 30.0)a||51.1 (± 31.0)a||52.1 (± 23.0)a||45.4 (± 21.3)a|
|SOP adherence (% of LOS)||77.3 (± 32.6)||79.0 (± 33.2)||68.9 (± 34.4)||69.3 (± 36.4)|
|DAU in agents per day||1.0 (0.5|1.5)||1.0 (0.5|1.5)||1.26 (± 0.65)||1.18 (± 0.74)|
|Antibiotic-free days (% of LOS)||28.8 (± 27.9)||27.3 (± 27.6)||22.0 (± 22.4)||25.4 (± 24.3)|
|Daily costs for antibiotics in €||19.3 (± 25.5)||15.6 (± 21.6)||30.7 (± 28.6)||26.7 (± 27.1)|
|Duration of treatment|
|ICU stay in days||4 (2|11)||4 (2|9.5)||10 (5|19)||10 (5|20)|
|Invasive ventilation in hoursb||27 (11|121)a||20 (8|95)a||96 (22|305)||85 (16|300)|
aP < 0.05 in two-tailed significance tests. bVentilated patients in main population, n = ♂ 331, ♀ 226; in sepsis subgroup, n = ♂ 182, ♀ 115. Binary parameters given in total and percentage (%), continuous variables presented in median and 25% and 75% quartiles (25%|75%) or mean (± STD). DAU, daily antibiotic use; LOS, length of stay; OP, operation; SAPS, simplified acute physiology score-II; SOFA, sequential organ-failure assessment; SOP, standard operating procedure; TISS-28, therapeutic intervention scoring system-28.
Distribution of infections, infection characteristics, and pathogens for main and sepsis population
|Main population||Sepsis population|
|Patients with infections n (%)||248 (62.0%)a||164 (53.1%)a||197 (100%)||130 (100%)|
|Colitis, pseudomembranous||2 (0.5%)||3 (1.0%)||2 (1.0%)||2 (1.5%)|
|Pneumonia||135 (33.8%)a||75 (24.3%)a||124 (62.9%)||70 (53.8%)|
|Lower urinary tract infections||13 (3.3%)a||34 (11.0%)a||11 (5.6%)a||30 (23.1%)a|
|Bones and joints||11 (2.8%)||7 (2.3%)||8 (4.1%)||6 (4.6%)|
|Endocarditis||11 (2.8%)||7 (2.3%)||10 (5.1%)||6 (4.6%)|
|Abdomen||40 (10.0%)||28 (9.1%)||32 (16.2%)||18 (13.8%)|
|Soft tissue and wounds||80 (20.0%)||47 (15.2%)||55 (27.9%)||38 (29.2%)|
|Upper urinary tract infections||6 (1.5%)||4 (1.3%)||3 (1.5%)||1 (0.8%)|
|Meningitis||5 (1.3%)||5 (1.6%)||4 (2.0%)||3 (2.3%)|
|Bloodstream infection||35 (8.8%)||17 (5.5)%)||34 (17.3%)||16 (12.3%)|
|Fever of unknown origin||33 (8.3%)||24 (7.8%)||22 (11.2%)||17 (13.1%)|
|Catheter-related infections||17 (4.3%)||5 (1.6%)||17 (8.6%)||5 (3.8%)|
|SIRS occurrence n (%)||364 (91.0%)||290 (93.9%)||197 (100%)||130 (100%)|
|Sepsis occurrence n (%)||197 (49.3%)||130 (42.1%)||197 (100%)||130 (100%)|
|Severe sepsis occurrence n (%)||89 (22.3%)a||48 (15.5%)a||89 (45.2%)||48 (36.9%)|
|Septic shock occurrence n (%)||74 (18,5%)||41 (13,3%)||74 (37.6%)||41 (31.5%)|
|Fungi detected||64 (16.0%)||47 (15.2%)||61 (31.0%)||42 (32.3%)|
|Gram-negative germs detected||98 (24.5%)||58 (18.8%)||89 (45.2%)||52 (40.0%)|
|Difficult-to-treat bacteria detected||41 (10.3%)||28 (9.1%)||37 (18.8%)||26 (20.0%)|
aP < 0.05 in a two-tailed χ2 test. More than one infection period per patient was possible. Difficult-to-treat pathogens include bacteria associated with potential intrinsic or acquired resistance (methicillin-resistant Staphylococcus aureus, germs producing extended spectrum betalactamases, Vancomycin-resistant Enterococci, nonfermenters like Pseudomonas spp., Stenotrophomonas maltophilia, Acinetobacter baumanii, Citrobacter spp., Enterobacter cloacae, Enterococcus faecium, and Bacillus cereus). Binary parameters presented in total and percentage (%). SIRS, systemic inflammatory response syndrome.
Effects of different factors on outcome in a mixed ICU population for study population
|Univariate logistic analysis||Multivariate logistic analysis|
|Parameter||OR (95% CI)||P||OR (95% CI)||P|
|Gender ♀ vs. ♂||1.209 (0.735-1.988)||0.455||1.277 (0.720-2.264)||0.403|
|Age||1.035 (1.015-1.055)||< 0.001||1.041 (1.018-1.064)||< 0.001|
|Alcohol abuse||1.341 (0.611-2.943)||0.464|
|Nicotine abuse||0.526 (0.186-1.490)||0.227|
|Drug abuse||0.976 (0.222-4.280)||0.974|
|Immune suppression||0.668 (0.234-1.904)||0.450|
|TISS-28 first||1.080 (1.053-1.108)||< 0.001||1.066 (1.035-1.097)||< 0.001|
|Infection during ICU stay||3.881 (1.745-8.633)||0.001||1.269 (0.487-3.304)||0.626|
|Pneumonia||4.370 (2.613-7.311)||< 0.001||1.377 (0.676-2.802)||0.378|
|Urinary tract infection||1.694 (0.728-3.941)||0.221|
|Bones and joints||1.164 (0.262-5.173)||0.842|
|Wounds/soft issue||1.310 (0.713-2.404)||0.384|
|Colitis, pseudomembranous||2.338 (0.258-21.220)||0.450|
|Infection of unknown origin||0.883 (0.341-2.292)||0.799|
|Severe sepsisa||4.110 (2.448-6.900)||< 0.001|
|Septic shock||5.023 (2.963-8.515)||< 0.001||2.746 (1.328-5.680)||0.006|
|Respiratory||4.306 (2.032-9.125)||< 0.001||1.447 (0.542-3.860)||0.461|
|Postoperative admission||0.865 (0.457-1.637)||0.655|
|Type of surgery|
|Soft tissues and peripheral vascular||4.803 (1.174-19.651)||0.029||3.509 (0.613-20.073)||0.158|
|Fungi detected||4.255 (2.492-7.266)||< 0.001||1.398 (0.701-2.788)||0.341|
|Gram-negative bacteria detected||2.929 (1.748-4.906)||< 0.001||1.234 (0.605-2.513)||0.563|
|Difficult-to-treat pathogens detectedb||2.421 (1.248-4.697)||0.009||1.115 (0.499-2.493)||0.791|
|SOP adherence ≤65%||1.705 (1.011-2.874)||0.045||2.309 (1.182-4.511)||0.014|
Effects of different factors on outcome in a mixed ICU population for study population (N = 709) by using univariate logistic regression analyses. Parameters found to be relevant on a P < 0.05 level for ICU mortality entered multivariate logistic regression analysis. Quality of regression model tested with the Hosmer-Lemeshow test, indicating good calibration (χ2 = 4.672; P = 0.792). BSI, bloodstream infection; SOP, standard operating procedure; TISS-28, therapeutic intervention scoring system-28.
aSeptic shock entered multivariate analysis due to correlation; bDifficult-to-treat pathogens include bacteria associated with potential intrinsic or acquired resistance (methicillin-resistant Staphylococcus aureus, germs producing extended spectrum betalactamases, vancomycin-resistant Enterococci, nonfermenters like Pseudomonas spp., Stenotrophomonas maltophilia, Acinetobacter baumanii, Citrobacter spp., Enterobacter cloacae, Enterococcus faecium, and Bacillus cereus).
Effects of different factors on outcome for sepsis subgroup (n = 327) by using univariate logistic regression analyses
|Univariate logistic analysis||Multivariate logistic analysis|
|Parameter||OR (95% CI)||P||OR (95% CI)||P|
|Gender ♀ vs. ♂||1.889 (1.062-3.359)||0.030||1.909 (1.002-3.638)||0.049|
|Age||1.036 (1.014-1.059)||0.001||1.037 (1.013-1.063)||0.003|
|Alcohol abuse||0.972 (0.408-2.317)||0.948|
|Nicotine abuse||0.428 (0.126-1.453)||0.174|
|Drug abuse||0.719 (0.158-3.277)||0.670|
|Immune suppression||0.740 (0.247-2.214)||0.590|
|TISS-28 first||1.063 (1.033-1.093)||< 0.001||1.062 (1.028-1.098)||< 0.001|
|Pneumonia||1.960 (1.048-3.664)||0.035||1.120 (0.539-2.324)||0.762|
|Urinary tract infection||0.790 (0.316-1.977)||0.614|
|Bones and joints||0.782 (0.170-3.593)||0.752|
|Wounds/Soft issue||0.787 (0.408-1.519)||0.476|
|Colitis, pseudomembranous||1.589 (0.162-15.560)||0.691|
|Infection of unknown origin||0.667 (0.249-1.788)||0.421|
|Severe sepsisa||1.845 (1.037-3.280)||0.037|
|Septic shock||2.418 (1.354-4.319)||0.003||1.649 (0.854-3.184)||0.136|
|Respiratory||2.523 (1.117-5.699)||0.026||1.374 (0.521-3.620)||0.520|
|Postoperative admission||1.165 (0.581-2.336)||0.667|
|Type of surgery|
|Soft tissues and peripheral vascular||3.694 (0.804-16.981)||0.093|
|Fungi detected||2.297 (1.282-4.118)||0.005||1.523 (0.782-2.968)||0.216|
|Gram-negative bacteria detected||1.341 (0.756-2.379)||0.315|
|Difficult-to-treat pathogens detectedb||1.300 (0.652-2.594)||0.457|
|SOP adherence ≤65%||1.139 (0.632-2.052)||0.664|
Parameters found to be relevant on a P < 0.05 level for ICU mortality entered multivariate logistic regression analysis. Quality of regression model tested with Hosmer-Lemeshow test indicating good calibration (χ2 = 7.014; P = 0.535). BSI, blood stream infection; SOP, standard operating procedure.
aSeptic shock entered multivariate analysis due to correlation; bDifficult-to-treat pathogens include bacteria associated with potential intrinsic or acquired resistance (methicillin-resistant Staphylococcus aureus, germs producing extended spectrum betalactamases, vancomycin-resistant Enterococci, Nonfermenters like Pseudomonas spp., Stenotrophomonas maltophilia, Acinetobacter baumanii, Citrobacter spp., Enterobacter cloacae, Enterococcus faecium, and Bacillus cereus).
Multivariate logistic regression analysis in a stepwise backward model
|Multivariate logistic analysis|
|Parameter||OR (95% CI)||P|
|Gender ♀ vs. ♂||1.966 (1.045-3.701)||0.036|
|TISS-28 first||1.069 (1.036-1.103)||< 0.001|
|Septic shock||1.831 (0.977-3.432)||0.059|
Multivariate logistic regression analysis in a stepwise backward model confirming associations with mortality shown in Table 4: Hosmer-Lemeshow test for the last step indicating good calibration (χ2 = 7.402; P = 0.494). TISS-28, therapeutic intervention scoring system-28.
Previous Document: Effect of the vitamin B12-binding protein haptocorrin present in human milk on a panel of commensal ...
Next Document: Deregulation upon DNA damage revealed by joint analysis of context-specific perturbation data.